Value of PET/CT in the management of liver metastases, part 1

Ari Sacks; Patrick J. Peller; Devaki S. Surasi; Luke Chatburn; Gustavo Mercier; Rathan M. Subramaniam

doi:10.2214/AJR.10.6331

Value of PET/CT in the management of liver metastases, part 1

Ari Sacks, Patrick J. Peller, Devaki S. Surasi, Luke Chatburn, Gustavo Mercier, Rathan M. Subramaniam

School of Medicine

Research output: Contribution to journal › Review article › peer-review

55 Scopus citations

Abstract

OBJECTIVE. Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis. CONCLUSION. For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.

Original language	English (US)
Pages (from-to)	W256-W259
Journal	American Journal of Roentgenology
Volume	197
Issue number	2
DOIs	https://doi.org/10.2214/AJR.10.6331
State	Published - Aug 1 2011

Keywords

F-FDG
Hepatobiliary tumors
PET/CT
Staging
Therapy assessment

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2214/AJR.10.6331

Cite this

@article{18c57d0300da4cf1a47a41092a1d1844,

title = "Value of PET/CT in the management of liver metastases, part 1",

abstract = "OBJECTIVE. Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis. CONCLUSION. For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.",

keywords = "F-FDG, Hepatobiliary tumors, PET/CT, Staging, Therapy assessment",

author = "Ari Sacks and Peller, {Patrick J.} and Surasi, {Devaki S.} and Luke Chatburn and Gustavo Mercier and Subramaniam, {Rathan M.}",

year = "2011",

month = aug,

day = "1",

doi = "10.2214/AJR.10.6331",

language = "English (US)",

volume = "197",

pages = "W256--W259",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "2",

}

TY - JOUR

T1 - Value of PET/CT in the management of liver metastases, part 1

AU - Sacks, Ari

AU - Peller, Patrick J.

AU - Surasi, Devaki S.

AU - Chatburn, Luke

AU - Mercier, Gustavo

AU - Subramaniam, Rathan M.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - OBJECTIVE. Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis. CONCLUSION. For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.

AB - OBJECTIVE. Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis. CONCLUSION. For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.

KW - F-FDG

KW - Hepatobiliary tumors

KW - PET/CT

KW - Staging

KW - Therapy assessment

UR - http://www.scopus.com/inward/record.url?scp=79960742153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960742153&partnerID=8YFLogxK

U2 - 10.2214/AJR.10.6331

DO - 10.2214/AJR.10.6331

M3 - Review article

C2 - 21785050

AN - SCOPUS:79960742153

SN - 0361-803X

VL - 197

SP - W256-W259

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

IS - 2

ER -

Value of PET/CT in the management of liver metastases, part 1

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this